|Videos|August 28, 2017

Addressing Challenges Faced by Hospital Epidemiologists

Silvia Munoz-Price, MD, PhD, shares a few issues that hospital epidemiologists currently face.

Silvia Munoz-Price, MD, PhD, associate professor of clinical medicine at the Institute for Health and Society, Medical College of Wisconsin, and enterprise epidemiologist for Froedtert & the Medical College of Wisconsin, shares a few issues that hospital epidemiologists currently face. Dr. Price stresses the need for a discussion regarding certification and what it should consist of. She also posits that the role of hospital epidemiologists is not clearly defined; the subspecialty is more than just implementing and following bundles. Lastly, Dr. Price calls for an expansion of the current research repertoire in order to better understand issues occurring in patient populations.


Related to this article

Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.